Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

计划入组 88 人 · 首次发布于 2021 年 11 月 26 日

Spinal Interneuron Excitability in ALS

计划入组 101 人 · 首次发布于 2015 年 4 月 29 日

Squamous cell carcinoma interferons (CECIN study)

计划入组 27 人

NRTX-1001

hiPSCs derived SST-GABAergic interneuron progenitors

human leukocyte-derived alpha interferons

VIA Pharmaceuticals, Inc.

United States

A2A Pharmaceuticals Inc.

United States

A2A Integrated Pharmaceuticals, LLC

United States

Engineered Human Spinal Interneurons Restore Breathing Function in Injured Rats, Paving Way for Regenerative Therapies

12-Gene Presymptomatic Signature and Vulnerable Trilaminar Interneurons Uncovered in Early Rett Syndrome

Mayo Clinic Launches Groundbreaking Neural Cell Therapy Trial for Drug-Resistant Epilepsy